Close Menu

NEW YORK (GenomeWeb) – Singapore-based Clearbridge Biomedics and Germany-based Leica Biosystems (LBS) have partnered to comarket each other's products in order support research on circulating tumor cells.

The companies will comarket Clearbridge's ClearCell CTC enrichment system and LBS' Bond Rx staining platform, creating an integrated and automated workflow for CTC enrichment and immunostaining.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.